6-propyl-2-piperidone | 140237-60-1

• 分子结构分类: 有机化合物 - 生物碱及其衍生物
• 英文名称: 6-propyl-2-piperidone
• 英文别名: 6-propylvalerolactam；6-propylpiperidin-2-one；6-Propyl-piperidin-2-on；6-n-propyl-piperidine-2-one
• CAS: 140237-60-1
• 化学式: C₈H₁₅NO
• mdl: MFCD19217031
• 分子量: 141.213
• InChiKey: JIGQDQXHKVNRJR-UHFFFAOYSA-N

物化性质

• 熔点：
  91.5-92.4 °C
• 沸点：
  146-148 °C(Press: 13 Torr)
• 密度：
  0.922±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.875
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  6-propyl-2-piperidone 在 氯化铵 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 70.0h， 生成 6-Propyl-piperidin-2-ylideneamine; hydrochloride
  参考文献：
  名称：

  Substituted 2-Iminopiperidines as Inhibitors of Human Nitric Oxide Synthase Isoforms

  摘要：

  A series of analogues of 2-iminopiperidine have been prepared and shown to be potent inhibitors of the human nitric oxide synthase (NOS) isoforms. Methyl substitutions on the 4-position (3) or 4- and 6-positions (8) afforded the most potent analogues. These compounds exibited IC50 values of 0.1 and 0.08 mu M, respectively, for hiNOS inhibition. Substitution with cyclohexylmethyl at the 6-position (13) afforded an inhibitor that showed the best selectivity for hiNOS versus heNOS (heNOS IC50/hiNOS IC50 = 64). Following oral administration, inhibitors were found to decrease serum nitrite/nitrate levels in an in vivo rat endotoxin assay. This series of 2-iminopiperidines were prepared via the described synthetic methodologies. The effect of ring substitutions on potency and selectivity for this class of cyclic amidines as NOS inhibitors is described.

  DOI：

  10.1021/jm9705059
• 作为产物：
  描述：

  6-(2-propenyl)piperidin-2-one 在 钯 作用下， 以 甲醇 为溶剂， 以to give the 6-n-propyl-piperidine-2-one的产率得到6-propyl-2-piperidone
  参考文献：
  名称：

  Heterobicyclic and tricyclic nitric oxide synthase inhibitors

  摘要：

  本发明涉及公式I的化合物，制药组合物和用作一氧化氮合酶抑制剂的使用方法，其中取代基在申请中定义。

  公开号：

  US06489323B1

文献信息

• Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
  申请人：Kelly G. Michael

  公开号：US20070225324A1

  公开（公告）日：2007-09-27

  Bicycloheteroaryl compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

  折环杂环芳基化合物的化学式如下所示： 这些化合物可以制备成药物组合物，并可用于预防和治疗包括人类在内的哺乳动物的各种疾病，例如疼痛、炎症、创伤等。
• Interrupted Pyridine Hydrogenation: Asymmetric Synthesis of δ‐Lactams
  作者：Tobias Wagener、Lukas Lückemeier、Constantin G. Daniliuc、Frank Glorius

  DOI：10.1002/anie.202016771

  日期：2021.3.15

  for increasing chemical complexity in a single reaction step. Overcoming the tenet of full reduction in arene hydrogenation has been seldom demonstrated. In this work we report the synthesis of sought‐after, enantioenriched δ‐lactams from oxazolidinone‐substituted pyridines and water by an interrupted hydrogenation mechanism.

  金属催化氢化是将容易获得的芳烃转化为饱和基序的有效方法，然而，目前的氢化策略仅限于形成C-H和N-H键。逐步添加氢气产生反应性不饱和中间体，并迅速还原。相比之下，通过不饱和中间体的进一步官能化来中断完全氢化为在单个反应步骤中增加化学复杂性提供了巨大的潜力。克服芳烃氢化完全还原的原则很少被证明。在这项工作中，我们报道了通过间断氢化机制从恶唑烷酮取代的吡啶和水合成广受欢迎的对映体富集的δ-内酰胺。
• Heterobicyclic and tricyclic nitric oxide synthase inhibitors
  申请人：——

  公开号：US20010044539A1

  公开（公告）日：2001-11-22

  The current invention discloses useful bicyclic and tricyclic amidino derivative compounds, pharmaceutical compositions containing these novel compounds, and to their use as nitric oxide synthase inhibitors.

  当前的发明揭示了有用的双环和三环氨基甲酰衍生物化合物，含有这些新化合物的药物组合物，以及它们作为一氧化氮合酶抑制剂的用途。
• Concise syntheses of substituted indolizidine alkaloids via cyclization based on α-sulfinyl carbanions: preparation of (±)-indolizidines 167B and 209D, their epimers, and (±)-tashiromine
  作者：Manat Pohmakotr、Saisuree Prateeptongkum、Soontorn Chooprayoon、Patoomratana Tuchinda、Vichai Reutrakul

  DOI：10.1016/j.tet.2008.01.008

  日期：2008.3

  (±)-Indolizidines 167B and 209D, their epimers and (±)-tashiromine have been successfully synthesized, starting from simple γ- or α-lactams. The strategy involves the cyclization of α-sulfinyl carbanion onto the carbonyl group of the lactam ring as the key step, leading to the indolizidines containing the phenylsulfinyl group, which are used as precursors for the preparation of the title compounds

  从简单的γ-或α-内酰胺开始，已经成功地合成了（±）-吲哚唑烷167B和209D，它们的差向异构体和（±）-tashiromine。该策略涉及将α-亚磺酰基碳负环到内酰胺环的羰基上的环化作为关键步骤，从而导致含有苯基亚磺酰基的吲哚并咪唑用作制备标题化合物的前体。
• Pyrrolo[1,2-b][1,2,4]oxadiazine diones useful as nitric oxide synthase inhibitors
  申请人：——

  公开号：US20040019019A1

  公开（公告）日：2004-01-29

  The current invention discloses useful bicyclic and tricyclic amidino derivative compounds, pharmaceutical compositions containing these novel compounds, and to their use as nitric oxide synthase inhibitors.

  当前发明揭示了有用的双环和三环氨基甲酰衍生物化合物，含有这些新化合物的制药组合物，并且它们作为一氧化氮合酶抑制剂的用途。